United States

Analyst Research Report Snapshot


Achillion Pharmaceuticals, Inc.






06 Jul 2015





Companies referenced:


Available for Immediate Download

Achillion Pharmaceuticals, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company. Features: - Detailed information on Achillion Pharmaceuticals, Inc. required for business and competitor intelligence needs - A study of the major internal and external factors affecting Achillion Pharmaceuticals, Inc. in the form of a SWOT analysis - An in-depth view of the business model of Achillion Pharmaceuticals, Inc. including a breakdown and examination of key business segments - Intelligence on Achillion Pharmaceuticals, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Achillion Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Achillion Pharmaceuticals (Achillion or ‘the company’) is a biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of infectious diseases such as chronic hepatitis C virus (HCV) and resistant bacterial infections. The company operates in the US where it is headquartered in New Haven, Connecticut. Achillion had 56 full-time employees and one part-time employee as of February 11, 2013. The company recorded revenues of $2.6 million during the financial year ended December 2012 (FY2012), an increase of 5.5% over FY2011. The operating loss of the company was $47.3 million in FY2012, as compared to an operating loss of $44.3 million over FY2011. The net loss was $47.1 million in FY2012, as compared to a net loss of $44.2 million over FY2011. Reasons to Purchase: - Gain understanding of Achillion Pharmaceuticals, Inc. and the factors that influence its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Achillion Pharmaceuticals, Inc. as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Achillion Pharmaceuticals, Inc.’s business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.